- Home
- ZDGE vs RLYB Comparison
ZDGE vs RLYB Comparison
Compare ZDGE & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- RLYB
- Stock Information
- Founded
- ZDGE 2008
- RLYB 2018
- Country
- ZDGE United States
- RLYB United States
- Employees
- ZDGE N/A
- RLYB N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- RLYB Health Care
- Exchange
- ZDGE Nasdaq
- RLYB Nasdaq
- Market Cap
- ZDGE 50.5M
- RLYB 45.2M
- IPO Year
- ZDGE N/A
- RLYB 2021
- Fundamental
- Price
- ZDGE $2.85
- RLYB $0.89
- Analyst Decision
- ZDGE
- RLYB Buy
- Analyst Count
- ZDGE 0
- RLYB 6
- Target Price
- ZDGE N/A
- RLYB $8.10
- AVG Volume (30 Days)
- ZDGE 207.2K
- RLYB 126.0K
- Earning Date
- ZDGE 12-16-2024
- RLYB 11-07-2024
- Dividend Yield
- ZDGE N/A
- RLYB N/A
- EPS Growth
- ZDGE N/A
- RLYB N/A
- EPS
- ZDGE N/A
- RLYB N/A
- Revenue
- ZDGE $30,204,000.00
- RLYB $598,000.00
- Revenue This Year
- ZDGE $16.71
- RLYB N/A
- Revenue Next Year
- ZDGE $16.10
- RLYB N/A
- P/E Ratio
- ZDGE N/A
- RLYB N/A
- Revenue Growth
- ZDGE 10.15
- RLYB N/A
- 52 Week Low
- ZDGE $1.93
- RLYB $0.84
- 52 Week High
- ZDGE $5.18
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- ZDGE 54.54
- RLYB 38.42
- Support Level
- ZDGE $1.93
- RLYB $0.84
- Resistance Level
- ZDGE $3.24
- RLYB $0.94
- Average True Range (ATR)
- ZDGE 0.34
- RLYB 0.07
- MACD
- ZDGE 0.07
- RLYB -0.02
- Stochastic Oscillator
- ZDGE 67.12
- RLYB 17.79
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.